The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 254 participants.
Also called NCT02452502
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 254 participants
- Sponsor
- Registry
-
NCT02452502
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02452502. Randomized; no masking; primary purpose treatment. Start 2015-09-02 (actual); primary completion 2017-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
- Acronym
- SEATIS
- Condition
- Stroke
- Intervention (Device)
- atorvastatin
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- The First Hospital of Jilin University
Record details
- Record id
cardio:ct-nct02452502- Content hash
7b6dff4a5bad8a2654a5b4fd016abef4aab3eb4b9cc2e93c5fb1b87d9e2e990d